Multi-institutional team chosen to probe cytoskeletal architecture in CTCs
The NIH-NCI Physical Sciences in Oncology Program has selected several multi-institutional teams for funding to probe heterogeneity in cancer systems. The multi-institutional team including USC, Moffitt Cancer Center, Cornell, and the Scripps Research Institute has been chosen to probe cytoskeletal architecture in circulating tumor cells. The Cornell team, led by Professor Kirby and including Drs. Giannakakou and Nanus at Weill Cornell Medical College, is focused on circulating tumor cell capture and assays of drug-target engagement in these cells.